Select region

Subscribe to our news feed

Subscribe

A question?

Contact us
21.10.2026

Getinge Interim Report July-September 2026: Increased profitability, strong cash flow and higher customer satisfaction

"We delivered organic growth both in order intake and in sales during the quarter, at the same time we increased profitability and generated strong cash flow.” says Mattias Perjos, President & CEO of Getinge.

Regulatory

21.10.2026
Getinge Interim Report July-September 2026: Increased profitability, strong cash flow and higher customer satisfaction

"We delivered organic growth both in order intake and in sales during the quarter, at the same time we increased profitability and generated strong cash flow.” says Mattias Perjos, President & CEO of Getinge.
15.10.2026

Nomination Committee appointed ahead of Getinge’s Annual General Meeting 2027

The members of the Nomination Committee for Getinge AB’s Annual General Meeting 2027 have now been appointed.

Regulatory

15.10.2026
Nomination Committee appointed ahead of Getinge’s Annual General Meeting 2027

The members of the Nomination Committee for Getinge AB’s Annual General Meeting 2027 have now been appointed.
13.10.2026

Getinge brings its smallest Edi catheter to the U.S. market following FDA clearance

New catheter extends NAVA-supported care to some of the smallest patients in neonatal intensive care, weighing between 500 and 1,000 grams.

Press release

13.10.2026
Getinge brings its smallest Edi catheter to the U.S. market following FDA clearance

New catheter extends NAVA-supported care to some of the smallest patients in neonatal intensive care, weighing between 500 and 1,000 grams.
07.10.2026

Getinge announces departure of Eric Honroth, President Life Science

Getinge today announced that Eric Honroth will resign as President Life Science and member of the Executive Team to accept an external opportunity.

Regulatory

07.10.2026
Getinge announces departure of Eric Honroth, President Life Science

Getinge today announced that Eric Honroth will resign as President Life Science and member of the Executive Team to accept an external opportunity.
07.10.2026

Getinge invites fund managers, analysts, and media to Q3 Report 2026 conference call

Getinge will issue its Q3 Report 2026 on October 21, 2026, at 08.00 a.m. CEST, followed by a conference call at 10.00 a.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.

Press release

07.10.2026
Getinge invites fund managers, analysts, and media to Q3 Report 2026 conference call

Getinge will issue its Q3 Report 2026 on October 21, 2026, at 08.00 a.m. CEST, followed by a conference call at 10.00 a.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.
25.09.2026

Insights from a fast-growing market

Over the past four years, Aruna Nayak has led Getinge’s operations in India through a period of strong growth, learning, and transformation.

News

25.09.2026
Insights from a fast-growing market

Over the past four years, Aruna Nayak has led Getinge’s operations in India through a period of strong growth, learning, and transformation.

Press Contacts

Caroline Örmgård, Getinge Head of Public & Media Relations

Caroline Örmgård

Phone: +46 10 335 0041

Email
Alexandra Holland

Alexandra Holland

Phone: +1 9737097000

Email
Newsroom2

Contact us online

Click below to fill in the appropriate form. We will be in touch shortly.

Fill the form

Are you looking for

Getinge Hybrid OR

Image Gallery

Diverse picture format made available for press article purpose 

Go the the Gallery
Man and woman looking a something together

About us

All you need to know about Getinge a one glance

Find more about Getinge
Cardiosave

Urgent Medical Device Correction

Voluntary Urgent Medical Device Field Correction for the CARDIOSAVE intra-aortic balloon pump (IABP)

Read the notice
Newsroom

Don't miss anything

Click on the icons and follow us!

 

     

Du forlater nå Getinge.com. Du kan få tilgang til innhold som ikke administreres av Getinge-teamet, i så fall kan ikke Getinge holdes ansvarlig for innholdet.

Jeg forstår! Bo på Getinge.com

Denne informasjonen er utelukkende ment for helsepersonell eller andre fagpersoner og er bare til orientering. Den er ikke uttømmende og erstatter derfor ikke bruksanvisningen, servicehåndboken eller medisinsk rådgivning. Getinge er ikke ansvarlig for det andre parter gjør eller ikke gjør på bakgrunn av dette materialet, og brukeren bærer risikoen for sin bruk av materialet.

Det er ikke sikkert behandlinger, løsninger eller produkter som nevnes i materialet, er tilgjengelige eller tillatt i det landet hvor du bor. Informasjonen kan verken helt eller delvis kopieres eller brukes uten skriftlig tillatelse fra Getinge.

Denne informasjonen er ment for et internasjonalt publikum utenfor USA.

De synspunkter, meninger og påstander som kommer til uttrykk, tilhører kun de intervjuede. De gjenspeiler eller representerer ikke nødvendigvis Getinges synspunkter.